drugset

drugset / Trial / NCT01304485

PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma

NCT01304485 ↗

Phase 2 Completed 2000 enrolled Phoenix Molecular Imaging

NaSingle-groupOpen-labelDiagnostic

Summary

Positron emission tomography (PET) imaging evaluation in men with recurrent prostate cancer to select patients who may benefit from directed therapy

Timeline

Start: 2011-04
Primary completion: 2019-01
Completion: 2019-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Sodium Acetate	Small molecule	—	—

Indications